ROCHESTER, Minn., Sept. 11 /PRNewswire-USNewswire/ — A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis MS. These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients’ outcomes. This study will be presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009.

Most MS genetic studies have looked at disease susceptibility — or why some people get MS and others do not,” says Allan Bieber, Ph.D., a Mayo Clinic neuroscientist and author of this study. “This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome.”

read the rest via Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis | Reuters.

Comments

Leave a Reply




  •  

     

     

     

  •  

     

     

  • Important Notice

    This site posts excerpts and summaries of articles of interest to people with multiple sclerosis and their families, along with links to the full articles in the journals in which they were published.

    I have multiple sclerosis (primary progressive), but I am neither a doctor nor a research scientist. I have no connection to the people mentioned in these articles, and have no more information about the subject of any given article than is contained in the article itself. Please do not ask me for medical advice or how to contact people mentioned in these articles. If contact information is not contained in the article itself, your best bet is to Google the name of the person, company or clinic you are seeking.